Your browser doesn't support javascript.
A medicinal chemist who reshaped the antiviral drug industry: John Charles Martin (1951-2021).
Li, Guangdi; De Clercq, Erik.
  • Li G; Hunan Provincial Key Laboratory of Clinical Epidemiology, Xiangya School of Public Health, Central South University, Changsha, China.
  • De Clercq E; KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Leuven, Belgium.
Med Res Rev ; 42(2): 647-653, 2022 03.
Article in English | MEDLINE | ID: covidwho-1718430
ABSTRACT
John Charles Martin should be remembered as a visionary medicinal chemist who was involved in the coinvention, development, or management of many FDA-approved antiviral drugs such as ganciclovir, stavudine, didanosine, cidofovir, oseltamivir, adefovir dipivoxil, tenofovir disoproxil fumarate, tenofovir alafenamide, sofosbuvir, and remdesivir.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents Limits: Humans Language: English Journal: Med Res Rev Year: 2022 Document Type: Article Affiliation country: Med.21858

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents Limits: Humans Language: English Journal: Med Res Rev Year: 2022 Document Type: Article Affiliation country: Med.21858